| Advantages | They provide a model for veterinary research and large-animal pulmonary disease studies, as well as supporting comparative lung development and agricultural applications. |
| Species | Ovine |
| Product Type | Tissue-derived Organoid |
| Growth Properties | Embedded 3D Culture |
| Growth Conditions | Cultured at 37°C under 95% air and 5% CO2. |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Lung |
| Disease | Normal |
| Format | Frozen |
| Organoid Characterization | Each batch is rigorously tested for mycoplasma, bacteria, and fungi/yeast, and verified for identity, genetic stability, and functional performance. |
| Applications | Tissue-derived organoids are widely employed in drug screening, disease modeling, mechanistic research, personalized medicine, and regenerative medicine. By recapitulating authentic disease states, they offer an optimal platform for evaluating patient-specific drug responses and aiding in personalized treatment design. Additionally, these organoids contribute to the development of novel therapeutic strategies, particularly in oncology and organ regeneration, providing sophisticated experimental tools that enhance progress in precision medicine. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.